Quick Reference Guides

Below are a number of slides created by our expert faculty which give a quick overview and easy reference of various key concepts in CSU diagnosis and management, such as 'Diagnostic algorithm' and 'Chronic urticaria subtypes'.

The following Quick Reference Guides are available to view and download as PDF documents.

  • Treatment algorithm

    An overview of the progression of treatment options, based on the EAACI/GA2LEN/EDF/WAO Guidelines (Zuberbier et al. Allergy 2014;69:868–87).

  • Differential diagnosis in patients with recurrent wheals

    This table gives a summary of how to distinguish between different potential causes of recurrent wheals (hives). Adapted from Maurer et al., Allergy 2013;68:816‒619.

  • Decision tree for wheals/angioedema

    This diagram provides a decision tree to assist in diagnosis of patients presenting with wheals (hives) and/or angioedema. Adapted from Zuberbier et al., Allergy 2014;69:868–87.

  • Diagnostic algorithm

    This diagram provides a simplified diagnostic algorithm to assist in determining the cause of hives/wheals. Adapted from Zuberbier et al., Allergy 2014;69:868–87.

  • Principles of antihistamine treatment

    This table outlines the rationale behind the use or avoidance of the various antihistamine classes in chronic spontaneous urticaria.

  • Chronic urticaria subtypes

    This table highlights the different subtypes of chronic urticaria, separating inducible forms from those which occur spontaneously/idiopathically. Adapted from Zuberbier et al., Allergy 2014;69:868–87.

  • Diagnostic tests

    A list of the routine and extended diagnostic tests recommended in the EAACI/GA2LEN/EDF/WAO guidelines. Adapted from Zuberbier et al., Allergy 2014;69:868–87.

  • Low-pseudoallergen diet

    This table provides a list of approved food types for use in patients where a low-pseudoallergen diet is recommended. Adapted from Zuberbier et al., Acta Derm Venereol (Stockh) 1995;75:484–7.

  • Overview of UAS7

    This slide summarises the use of the Urticaria Activity Score over 7 days, to generate a UAS7. Adapted from Zuberbier et al., Allergy 2014;69:868–87.

  • Use of the DLQI assessment

    This slide provides a summary of the Dermatology Life Quality Index tool, showing the domains which are measured.

Login/ Register Maximise Minimise